Leiter, L. A. Et Al. 2016. Implementing an optimized glucose-lowering strategy with a novel once daily modified release gliclazide formulation. DIABETES RESEARCH AND CLINICAL PRACTICE , vol.112 , 50-56.

Leiter, L. A., Shestakova, M. V., Trubitsyna, N. P., Piletic, M., & Satman, I., (2016). Implementing an optimized glucose-lowering strategy with a novel once daily modified release gliclazide formulation. DIABETES RESEARCH AND CLINICAL PRACTICE , vol.112, 50-56.

Leiter, Lawrence Et Al. "Implementing an optimized glucose-lowering strategy with a novel once daily modified release gliclazide formulation," DIABETES RESEARCH AND CLINICAL PRACTICE , vol.112, 50-56, 2016

Leiter, Lawrence A. Et Al. "Implementing an optimized glucose-lowering strategy with a novel once daily modified release gliclazide formulation." DIABETES RESEARCH AND CLINICAL PRACTICE , vol.112, pp.50-56, 2016

Leiter, L. A. Et Al. (2016) . "Implementing an optimized glucose-lowering strategy with a novel once daily modified release gliclazide formulation." DIABETES RESEARCH AND CLINICAL PRACTICE , vol.112, pp.50-56.

@article{article, author={Lawrence A. Leiter Et Al. }, title={Implementing an optimized glucose-lowering strategy with a novel once daily modified release gliclazide formulation}, journal={DIABETES RESEARCH AND CLINICAL PRACTICE}, year=2016, pages={50-56} }